Search bioRxiv⌕ Search

Biology subjects

Roosta, F.

Publications and source records attributed to Roosta, F..

2 recordsLinked to original sources

STimage:robust, confident and interpretable models for predicting gene markers from cancer histopathological images

Spatial transcriptomic (ST) imaging and sequencing data enable us to link tissue morphological features with thousands of previously unseen gene expression values, opening a new horizon for understanding tissue biology and achieving breakthroughs in digital pathology. Deep learning models are emerging to predict gene expression or classify cell types using images as the sole input. Such models hold significant potential for clinical applications, but require improvements in interpretability and robustness. We developed STimage as a comprehensive suite of models for both regression (predicting gene expression) and classification (mapping tissue regions and cell types) tasks. STimage is the first to thoroughly address robustness (uncertainty) and interpretability. For robustness, STimage predicts gene expression based on parameter distributions rather than fixed data points, allowing for generalisation at a population scale. STimage estimates uncertainty from the data (aleatoric) and from the model (epistemic) for each of thousands of imaging tiles. STimage achieves interpretability by analysing model attribution at a single-cell level, and in the context of histopathological annotation. While existing models focus on predicting highly variable genes, STimage predicts functional genes and identifies highly predictable genes. Using diverse datasets from three cancers and one chronic disease, we assessed the models performance on in-distribution and out-of-distribution samples. STimage is robust to technical variations across platforms, data types, sample preservation methods, and disease types. Further, we implemented an ensemble approach, incorporating pre-trained foundation models, to improve performance and reliability, especially in cases with small training datasets. With single-cell resolution Xenium data, STimage could classify cell types for millions of individual cells. Applying STimage to proteomics data such as CODEX, we found that STimage can predict gene expression consistent with protein expression patterns. Finally, we showed that using STimage-predicted values based solely on imaging input, we could stratify patient survival groups. Overall, STimage advances spatial transcriptomics by improving the prediction of gene expression from traditional histopathological images, making it more accessible for tissue biology research and digital pathology applications.

bioinformatics↗

Generalising uncertainty improves accuracy and safety of deep learning analytics applied to oncology

Trust and transparency are critical for deploying deep learning (DL) models into the clinic. DL application poses generalisation obstacles since training/development datasets often have different data distributions to clinical/production datasets that can lead to incorrect predictions with underestimated uncertainty. To investigate this pitfall, we benchmarked one pointwise and three approximate Bayesian DL models used to predict cancer of unknown primary with three independent RNA-seq datasets covering 10,968 samples across 57 primary cancer types. Our results highlight simple and scalable Bayesian DL significantly improves the generalisation of uncertainty estimation (e.g., p-value = 0.0013 for calibration). Moreover, we demonstrate Bayesian DL substantially improves accuracy under data distributional shifts when utilising uncertainty thresholding by designing a prototypical metric that evaluates the expected (accuracy) loss when deploying models from development to production, which we call the Area between Development and Production curve (ADP). In summary, Bayesian DL is a hopeful avenue of research for generalising uncertainty, which improves performance, transparency, and therefore safety of DL models for deployment in real-world.

bioinformatics↗